FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved Eisai Inc.'s supplemental application for ARICEPT (donepezil hydrochloride), resulting in an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

SUPPL AP for ARICEPT (DONEPEZIL HYDROCHLORIDE)